Effects of paricalcitol and aliskiren combination therapy on experimental diabetic nephropathy model in rats

Autor: Eren, Z., Günal, M.Y., Bakir, E.A., Coban, J., Ça?layan, B., Ekimci, N., Kantarci, G.
Přispěvatelé: Eren, Z., Günal, M.Y., Bakir, E.A., Coban, J., Ça?layan, B., Ekimci, N., Kantarci, G., Yeditepe Üniversitesi
Jazyk: angličtina
Rok vydání: 2014
Předmět:
Popis: Background/Aims: The aim of the present study was to investigate the effect of combination of aliskiren with paricalcitol on experimental diabetic nephropathy (DN) model in rats. Methods: Forty male Sprague Dawley rats were divided into 5 groups of 8 rats each, namely the control (Group C), diabetes (Group D), aliskiren (Group A), paricalcitol (Group P), and aliskiren plus paricalcitol (Group A+P) groups. Aliskiren was given by oral-gavage at a dose of 50 mg/kg/day once daily for 12 weeks. Paricalcitol was given by intraperitoneally at a dose of 0,4 µg/kg/three day of week for 12 weeks. Renal function parameters, oxidative stress biomarkers, mRNA expression of renin-angiotensin system parameters and kidney histology were determined. Results: Group A+P had lower mean albümin-to-creatinine ratio (ACR) (p=0.004) as well as higher creatinine clearance (CCr) (p
Databáze: OpenAIRE